Stakeholder Political Alliance for Radioligand Cancer Therapies
Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 23 Jan 2025 | Christophe Galand Head of Unit | Discussion on research place in the the future Multiannual Financial Framework | — |
| 23 Jan 2025 | Christophe Galand Head of Unit | Discussion on research place in the the future Multiannual Financial Framework | SRC |
Mission & Goals
SPARC-Europe is a European policy initiative, launched in October 2020, aiming to build a comprehensive policy framework for radioligand therapies. The mission of the group is to provide expert knowledge and the necessary guidance for policymakers to support them in the creation of a clear pathway to institutionalise radioligand therapies and increase its accessibility for patients. The overarching objective of the group is to work together with its Patron policymakers towards accommodating European innovation and changing the outcomes for cancer patients.
EU Legislative Interests
Europe's Beating Cancer Plan Strategic Agenda for Medical, Industrial and Research Applications (SAMIRA) EU4Health Programme Pharmaceutical legislation BioTech Act Health Workforce Multiannual Financial Framework 28-34
Communication Activities
High-Level Position Paper on improving Access to Radioligand Cancer Therapies in the Context of Europe's Beating Cancer Plan. Investment Pathway Guide for the delivery of radioligand cancer therapies, looking into the potential offered by EU funding instruments in tackling inequalities in hospital infrastructures.
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
https://sparc-europe.com/governance
Organisation Members
https://sparc-europe.com/about/members